Identification of the hemodynamic modulators and hemodynamic status in uncontrolled hypertensive patients

Figures & data

Table I. Blood pressure and hemodynamic parameters in the study group.

Number of participants	134
Systolic blood pressure, mmHg	156.0 ± 21.7
Diastolic blood pressure, mmHg	91.9 ± 13.0
Mean blood pressure, mmHg	113.3 ± 14.0
Cardiac index, l/min/m^2	3.4 ± 1.5
Stroke index, ml/beat/m^2	49.6 ± 19.9
ISI, sec^− 2	0.99 ± 0.36
LSWI, g.m/m^2	74.5 ± 28.9
SSVRI, dyn.sec.cm^− 5.m^2	217.2 ± 121

Data are mean± SD. ISI, inotropic state index; LSWI, left stroke work index; SSVRI, stroke systemic vascular resistance index.

Figure 1. Numbers of antihypertensive drugs used by participants of the study.

Figure 2. Antihypertensive drug usage in study group.

Figure 3. Scattergram of hemodynamic state of all patients measured in the study with superimposed percentage of correspondent hemodynamic states.

Figure 4. Hemodynamic modulators distribution.

Figure 5. Subgroup distribution according to number of altered modulators.

Table II. Complete hemodynamic profile and drug distribution in each subgroup.

VD, vasodilator; BB, beta-blocker; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blockers; CCB, calcium-channel blocker; DHP, dihydropyridine.